{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T21:05:29Z","timestamp":1793480729459,"version":"4.5.0"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:00:00Z","timestamp":1767139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-67744-y","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T14:03:22Z","timestamp":1767189802000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["4R-tau seeding activity reveals molecular subtypes in progressive supranuclear palsy"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6463-6321","authenticated-orcid":false,"given":"Ivan","family":"Martinez-Valbuena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seojin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8046-8102","authenticated-orcid":false,"given":"Enrique","family":"Santamaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5072-4099","authenticated-orcid":false,"given":"Joaqu\u00edn","family":"Fern\u00e1ndez-Irigoyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelley L.","family":"Forrest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0134-0974","authenticated-orcid":false,"given":"Silvia","family":"Zampar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8490-3877","authenticated-orcid":false,"given":"Hidetomo","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3512-7488","authenticated-orcid":false,"given":"Blas","family":"Couto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolai","family":"Gil D. Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4855-1860","authenticated-orcid":false,"given":"Syeda Hania","family":"Qamar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali M.","family":"Karakani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ain","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3407-5716","authenticated-orcid":false,"given":"Konstantin","family":"Senkevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2852-0329","authenticated-orcid":false,"given":"Ekaterina","family":"Rogaeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan H.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5944-8497","authenticated-orcid":false,"given":"M. Carmela","family":"Tartaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi P.","family":"Visanji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5466-8370","authenticated-orcid":false,"given":"Martin","family":"Ingelsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1120-2196","authenticated-orcid":false,"given":"Tallulah","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony E.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3841-5511","authenticated-orcid":false,"given":"Gabor G.","family":"Kovacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,31]]},"reference":[{"key":"67744_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2019.101644","volume":"180","author":"TW Roesler","year":"2019","unstructured":"Roesler, T. W. et al. Four-repeat tauopathies. Prog. Neurobiol. 180, 101644 (2019).","journal-title":"Prog. Neurobiol."},{"key":"67744_CR2","doi-asserted-by":"publisher","first-page":"II6","DOI":"10.1007\/BF03161076","volume":"246","author":"DW Dickson","year":"1999","unstructured":"Dickson, D. W. Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration. J. Neurol. 246, II6\u2013II15 (1999).","journal-title":"J. Neurol."},{"key":"67744_CR3","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1212\/WNL.44.11.2015","volume":"44","author":"J-J Hauw","year":"1994","unstructured":"Hauw, J.-J. et al. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 44, 2015\u20132015 (1994).","journal-title":"Neurology"},{"key":"67744_CR4","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s00401-022-02479-4","volume":"144","author":"SF Roemer","year":"2022","unstructured":"Roemer, S. F. et al. Rainwater Charitable Foundation criteria for the neuropathologic diagnosis of progressive supranuclear palsy. Acta Neuropathol. 144, 603\u2013614 (2022).","journal-title":"Acta Neuropathol."},{"key":"67744_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/nan.12208","volume":"41","author":"GG Kovacs","year":"2015","unstructured":"Kovacs, G. G. Invited review: neuropathology of tauopathies: principles and practice. Neuropathol. Appl. Neurobiol. 41, 3\u201323 (2015).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"67744_CR6","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/mds.26987","volume":"32","author":"GU H\u00f6glinger","year":"2017","unstructured":"H\u00f6glinger, G. U. et al. Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov. Disord. 32, 853\u2013864 (2017).","journal-title":"Mov. Disord."},{"key":"67744_CR7","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1002\/mds.26054","volume":"29","author":"G Respondek","year":"2014","unstructured":"Respondek, G. et al. The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases. Mov. Disord. 29, 1758\u20131766 (2014).","journal-title":"Mov. Disord."},{"key":"67744_CR8","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1146\/annurev-neuro-072116-031153","volume":"40","author":"M Goedert","year":"2017","unstructured":"Goedert, M., Eisenberg, D. S. & Crowther, R. A. Propagation of tau aggregates and neurodegeneration. Annu. Rev. Neurosci. 40, 189\u2013210 (2017).","journal-title":"Annu. Rev. Neurosci."},{"key":"67744_CR9","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1146\/annurev-med-042921-023749","volume":"74","author":"B Hyman","year":"2023","unstructured":"Hyman, B. All the Tau we cannot see. Annu. Rev. Med. 74, 503\u2013514 (2023).","journal-title":"Annu. Rev. Med."},{"key":"67744_CR10","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.neuron.2014.04.047","volume":"82","author":"DW Sanders","year":"2014","unstructured":"Sanders, D. W. et al. Distinct tau prion strains propagate in cells and mice and define different tauopathies. Neuron 82, 1271\u20131288 (2014).","journal-title":"Neuron"},{"key":"67744_CR11","doi-asserted-by":"publisher","first-page":"9535","DOI":"10.1073\/pnas.1301175110","volume":"110","author":"F Clavaguera","year":"2013","unstructured":"Clavaguera, F. et al. Brain homogenates from human tauopathies induce tau inclusions in mouse brain. Proc. Natl. Acad. Sci. USA 110, 9535\u20139540 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"67744_CR12","doi-asserted-by":"crossref","unstructured":"Mirbaha, H. et al. Inert and seed-competent tau monomers suggest structural origins of aggregation. Elife 7, e36584 (2018).","DOI":"10.7554\/eLife.36584"},{"key":"67744_CR13","doi-asserted-by":"crossref","unstructured":"Narasimhan, S. et al. Human tau pathology transmits glial tau aggregates in the absence of neuronal tau. J. Exp. Med. 217, e20190783 (2020).","DOI":"10.1084\/jem.20190783"},{"key":"67744_CR14","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3389\/fnagi.2019.00112","volume":"11","author":"I Ferrer","year":"2019","unstructured":"Ferrer, I. et al. Involvement of Oligodendrocytes in Tau Seeding and Spreading in Tauopathies. Front. Aging Neurosci. 11, 112 (2019).","journal-title":"Front. Aging Neurosci."},{"key":"67744_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13787-x","volume":"11","author":"Z He","year":"2020","unstructured":"He, Z. et al. Transmission of tauopathy strains is independent of their isoform composition. Nat. Commun. 11, 7 (2020).","journal-title":"Nat. Commun."},{"key":"67744_CR16","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00401-020-02253-4","volume":"141","author":"H Xu","year":"2021","unstructured":"Xu, H. et al. In vitro amplification of pathogenic tau conserves disease-specific bioactive characteristics. Acta Neuropathol. 141, 193\u2013215 (2021).","journal-title":"Acta Neuropathol."},{"key":"67744_CR17","doi-asserted-by":"publisher","first-page":"1433465","DOI":"10.3389\/fnins.2024.1433465","volume":"18","author":"SH Priyanka, Qamar","year":"2024","unstructured":"Priyanka, Qamar, S. H. & Visanji, N. P. Toward an animal model of Progressive Supranuclear Palsy. Front. Neurosci. 18, 1433465 (2024).","journal-title":"Front. Neurosci."},{"key":"67744_CR18","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1093\/brain\/awac428","volume":"146","author":"M Darricau","year":"2023","unstructured":"Darricau, M. et al. Tau seeds from patients induce progressive supranuclear palsy pathology and symptoms in primates. Brain 146, 2524\u20132534 (2023).","journal-title":"Brain"},{"key":"67744_CR19","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41586-021-03911-7","volume":"598","author":"Y Shi","year":"2021","unstructured":"Shi, Y. et al. Structure-based classification of tauopathies. Nature 598, 359\u2013363 (2021).","journal-title":"Nature"},{"key":"67744_CR20","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00401-020-02158-2","volume":"140","author":"GG Kovacs","year":"2020","unstructured":"Kovacs, G. G. et al. Distribution patterns of tau pathology in progressive supranuclear palsy. Acta Neuropathol. 140, 99\u2013119 (2020).","journal-title":"Acta Neuropathol."},{"key":"67744_CR21","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1002\/mds.27816","volume":"34","author":"N Sakae","year":"2019","unstructured":"Sakae, N. et al. Neuropathologic basis of frontotemporal dementia in progressive supranuclear palsy. Mov. Disord. 34, 1655\u20131662 (2019).","journal-title":"Mov. Disord."},{"key":"67744_CR22","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1093\/brain\/awh488","volume":"128","author":"DR Williams","year":"2005","unstructured":"Williams, D. R. et al. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson\u2019s syndrome and PSP-parkinsonism. Brain 128, 1247\u20131258 (2005).","journal-title":"Brain"},{"key":"67744_CR23","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1093\/brain\/awm104","volume":"130","author":"DR Williams","year":"2007","unstructured":"Williams, D. R. et al. Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson\u2019s syndrome. Brain 130, 1566\u20131576 (2007).","journal-title":"Brain"},{"key":"67744_CR24","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1002\/mds.20478","volume":"20","author":"Y Tsuboi","year":"2005","unstructured":"Tsuboi, Y. et al. Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome. Mov. Disord. 20, 982\u2013988 (2005).","journal-title":"Mov. Disord."},{"key":"67744_CR25","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1093\/brain\/awm301","volume":"131","author":"Z Ahmed","year":"2008","unstructured":"Ahmed, Z., Josephs, K. A., Gonzalez, J., DelleDonne, A. & Dickson, D. W. Clinical and neuropathologic features of progressive supranuclear palsy with severe pallido-nigro-luysial degeneration and axonal dystrophy. Brain 131, 460\u2013472 (2008).","journal-title":"Brain"},{"key":"67744_CR26","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1002\/mds.28011","volume":"35","author":"M Jecmenica Lukic","year":"2020","unstructured":"Jecmenica Lukic, M. et al. Copathology in progressive supranuclear palsy: does it matter? Mov. Disord. 35, 984\u2013993 (2020).","journal-title":"Mov. Disord."},{"key":"67744_CR27","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1111\/ene.15346","volume":"29","author":"B Couto","year":"2022","unstructured":"Couto, B. et al. Protracted course progressive supranuclear palsy. Eur. J. Neurol. 29, 2220\u20132231 (2022).","journal-title":"Eur. J. Neurol."},{"key":"67744_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9490","volume":"6","author":"S Takeda","year":"2015","unstructured":"Takeda, S. et al. Neuronal uptake and propagation of a rare phosphorylated high-molecular-weight tau derived from Alzheimer\u2019s disease brain. Nat. Commun. 6, 8490 (2015).","journal-title":"Nat. Commun."},{"key":"67744_CR29","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/ana.24716","volume":"80","author":"S Takeda","year":"2016","unstructured":"Takeda, S. et al. Seed-competent high-molecular-weight tau species accumulates in the cerebrospinal fluid of Alzheimer\u2019s disease mouse model and human patients. Ann. Neurol. 80, 355\u2013367 (2016).","journal-title":"Ann. Neurol."},{"key":"67744_CR30","doi-asserted-by":"publisher","first-page":"e70160","DOI":"10.1096\/fj.202401704R","volume":"38","author":"H Fukumoto","year":"2024","unstructured":"Fukumoto, H., Kao, T. H., Tai, C. Y., Jang, M. K. & Miyamoto, M. High-molecular-weight oligomer tau (HMWoTau) species are dramatically increased in Braak-stage dependent manner in the frontal lobe of human brains, demonstrated by a novel oligomer Tau ELISA with a mouse monoclonal antibody (APNmAb005). FASEB J. 38, e70160 (2024).","journal-title":"FASEB J."},{"key":"67744_CR31","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1038\/s41591-020-0938-9","volume":"26","author":"S Dujardin","year":"2020","unstructured":"Dujardin, S. et al. Tau molecular diversity contributes to clinical heterogeneity in Alzheimer\u2019s disease. Nat. Med. 26, 1256\u20131263 (2020).","journal-title":"Nat. Med."},{"key":"67744_CR32","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s00401-023-02600-1","volume":"146","author":"A Mate De Gerando","year":"2023","unstructured":"Mate De Gerando, A. et al. Tau seeding and spreading in vivo is supported by both AD-derived fibrillar and oligomeric tau. Acta Neuropathol. 146, 191\u2013210 (2023).","journal-title":"Acta Neuropathol."},{"key":"67744_CR33","doi-asserted-by":"publisher","first-page":"3775","DOI":"10.1016\/j.cell.2025.04.006","volume":"188","author":"SS Harris","year":"2025","unstructured":"Harris, S. S. et al. Alzheimer\u2019s disease patient-derived high-molecular-weight tau impairs bursting in hippocampal neurons. Cell 188, 3775\u20133788.e3721 (2025).","journal-title":"Cell"},{"key":"67744_CR34","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abg0253","volume":"14","author":"C Kim","year":"2022","unstructured":"Kim, C. et al. Distinct populations of highly potent TAU seed conformers in rapidly progressing Alzheimer\u2019s disease. Sci. Transl. Med. 14, eabg0253 (2022).","journal-title":"Sci. Transl. Med."},{"key":"67744_CR35","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1002\/acn3.50897","volume":"6","author":"M Bongianni","year":"2019","unstructured":"Bongianni, M. et al. \u03b1-Synuclein RT-QuIC assay in cerebrospinal fluid of patients with dementia with Lewy bodies. Ann. Clin. Transl. Neurol. 6, 2120\u20132126 (2019).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"67744_CR36","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s00401-022-02453-0","volume":"144","author":"I Martinez-Valbuena","year":"2022","unstructured":"Martinez-Valbuena, I. et al. \u03b1-Synuclein molecular behavior and nigral proteomic profiling distinguish subtypes of Lewy body disorders. Acta Neuropathol. 144, 167\u2013185 (2022).","journal-title":"Acta Neuropathol."},{"key":"67744_CR37","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1001\/jamaneurol.2024.3162","volume":"81","author":"I Martinez-Valbuena","year":"2024","unstructured":"Martinez-Valbuena, I., Tartaglia, M. C., Fox, S. H., Lang, A. E. & Kovacs, G. G. Four-repeat Tau seeding in the skin of patients with progressive supranuclear palsy. JAMA Neurol. 81, 1228\u20131230 (2024).","journal-title":"JAMA Neurol."},{"key":"67744_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-022-00283-4","volume":"11","author":"I Martinez-Valbuena","year":"2022","unstructured":"Martinez-Valbuena, I. et al. Alpha-synuclein seeding shows a wide heterogeneity in multiple system atrophy. Transl. Neurodegener. 11, 7 (2022).","journal-title":"Transl. Neurodegener."},{"key":"67744_CR39","doi-asserted-by":"publisher","first-page":"E4376","DOI":"10.1073\/pnas.1411649111","volume":"111","author":"BB Holmes","year":"2014","unstructured":"Holmes, B. B. et al. Proteopathic tau seeding predicts tauopathy in vivo. Proc. Natl. Acad. Sci. 111, E4376\u2013E4385 (2014).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"67744_CR40","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41593-019-0541-x","volume":"23","author":"A Lau","year":"2020","unstructured":"Lau, A. et al. \u03b1-Synuclein strains target distinct brain regions and cell types. Nat. Neurosci. 23, 21\u201331 (2020).","journal-title":"Nat. Neurosci."},{"key":"67744_CR41","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1093\/brain\/awaa223","volume":"143","author":"E Drummond","year":"2020","unstructured":"Drummond, E. et al. Phosphorylated tau interactome in the human Alzheimer\u2019s disease brain. Brain 143, 2803\u20132817 (2020).","journal-title":"Brain"},{"key":"67744_CR42","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1016\/j.cell.2024.02.031","volume":"187","author":"SS Pineda","year":"2024","unstructured":"Pineda, S. S. et al. Single-cell dissection of the human motor and prefrontal cortices in ALS and FTLD. Cell 187, 1971\u20131989.e1916 (2024).","journal-title":"Cell"},{"key":"67744_CR43","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1038\/s41593-022-01191-6","volume":"25","author":"P Martinez","year":"2022","unstructured":"Martinez, P. et al. Bassoon contributes to tau-seed propagation and neurotoxicity. Nat. Neurosci. 25, 1597\u20131607 (2022).","journal-title":"Nat. Neurosci."},{"key":"67744_CR44","doi-asserted-by":"crossref","unstructured":"Martinez-Valbuena I. Phenotype parallels protein seeding capacity in neurodegenerative diseases. Brain Pathol. 34, e13238 (2024).","DOI":"10.1111\/bpa.13238"},{"key":"67744_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52025-x","volume":"15","author":"K Farrell","year":"2024","unstructured":"Farrell, K. et al. Genetic, transcriptomic, histological, and biochemical analysis of progressive supranuclear palsy implicates glial activation and novel risk genes. Nat. Commun. 15, 7880 (2024).","journal-title":"Nat. Commun."},{"key":"67744_CR46","doi-asserted-by":"publisher","first-page":"5753","DOI":"10.1016\/j.cell.2024.08.019","volume":"187","author":"JE Rexach","year":"2024","unstructured":"Rexach, J. E. et al. Cross-disorder and disease-specific pathways in dementia revealed by single-cell genomics. Cell 187, 5753\u20135774.e5728 (2024).","journal-title":"Cell"},{"key":"67744_CR47","doi-asserted-by":"crossref","unstructured":"Wang, X. et al. Alzheimer\u2019s disease and progressive supranuclear palsy share similar transcriptomic changes in distinct brain regions. J. Clin. Invest. 132, e149904 (2022).","DOI":"10.1172\/JCI149904"},{"key":"67744_CR48","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s00401-024-02823-w","volume":"148","author":"K Whitney","year":"2024","unstructured":"Whitney, K. et al. Single-cell transcriptomic and neuropathologic analysis reveals dysregulation of the integrated stress response in progressive supranuclear palsy. Acta Neuropathol. 148, 80 (2024).","journal-title":"Acta Neuropathol."},{"key":"67744_CR49","doi-asserted-by":"publisher","first-page":"12887","DOI":"10.1523\/JNEUROSCI.2107-13.2013","volume":"33","author":"SL DeVos","year":"2013","unstructured":"DeVos, S. L. et al. Antisense reduction of tau in adult mice protects against seizures. J. Neurosci. 33, 12887\u201312897 (2013).","journal-title":"J. Neurosci."},{"key":"67744_CR50","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1038\/nn.4328","volume":"19","author":"JW Wu","year":"2016","unstructured":"Wu, J. W. et al. Neuronal activity enhances tau propagation and tau pathology in vivo. Nat. Neurosci. 19, 1085\u20131092 (2016).","journal-title":"Nat. Neurosci."},{"key":"67744_CR51","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/alzrt243","volume":"6","author":"F Fecto","year":"2014","unstructured":"Fecto, F., Esengul, Y. T. & Siddique, T. Protein recycling pathways in neurodegenerative diseases. Alzheimers Res. Ther. 6, 13 (2014).","journal-title":"Alzheimers Res. Ther."},{"key":"67744_CR52","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.neuron.2018.07.039","volume":"99","author":"B Eftekharzadeh","year":"2018","unstructured":"Eftekharzadeh, B. et al. Tau protein disrupts nucleocytoplasmic transport in Alzheimer\u2019s disease. Neuron 99, 925\u2013940.e927 (2018).","journal-title":"Neuron"},{"key":"67744_CR53","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/978-3-319-08927-0_3","volume":"822","author":"B Wolozin","year":"2015","unstructured":"Wolozin, B. & Apicco, D. RNA binding proteins and the genesis of neurodegenerative diseases. Adv. Exp. Med Biol. 822, 11\u201315 (2015).","journal-title":"Adv. Exp. Med Biol."},{"key":"67744_CR54","doi-asserted-by":"publisher","first-page":"698661","DOI":"10.3389\/fcell.2021.698661","volume":"9","author":"S Nandakumar","year":"2021","unstructured":"Nandakumar, S., Rozich, E. & Buttitta, L. Cell cycle re-entry in the nervous system: from polyploidy to neurodegeneration. Front. Cell Dev. Biol. 9, 698661 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"67744_CR55","doi-asserted-by":"publisher","first-page":"9232","DOI":"10.1523\/JNEUROSCI.3347-04.2004","volume":"24","author":"K Herrup","year":"2004","unstructured":"Herrup, K., Neve, R., Ackerman, S. L. & Copani, A. Divide and die: cell cycle events as triggers of nerve cell death. J. Neurosci. 24, 9232\u20139239 (2004).","journal-title":"J. Neurosci."},{"key":"67744_CR56","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.3389\/fphar.2019.01008","volume":"10","author":"L Guzman-Martinez","year":"2019","unstructured":"Guzman-Martinez, L. et al. Neuroinflammation as a common feature of neurodegenerative disorders. Front. Pharmacol. 10, 1008 (2019).","journal-title":"Front. Pharmacol."},{"key":"67744_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40035-020-00221-2","volume":"9","author":"HS Kwon","year":"2020","unstructured":"Kwon, H. S. & Koh, S.-H. Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes. Transl. Neurodegener. 9, 1\u201312 (2020).","journal-title":"Transl. Neurodegener."},{"key":"67744_CR58","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/S1474-4422(23)00038-8","volume":"22","author":"C Langworth-Green","year":"2023","unstructured":"Langworth-Green, C. et al. Chronic effects of inflammation on tauopathies.  Lancet Neurol. 22, 430\u2013442 (2023).","journal-title":"Lancet Neurol."},{"key":"67744_CR59","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/s41586-023-05788-0","volume":"615","author":"X Chen","year":"2023","unstructured":"Chen, X. et al. Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy. Nature 615, 668\u2013677 (2023).","journal-title":"Nature"},{"key":"67744_CR60","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1136\/jnnp-2020-325549","volume":"92","author":"M Malpetti","year":"2021","unstructured":"Malpetti, M. et al. Neuroinflammation predicts disease progression in progressive supranuclear palsy. J. Neurol. Neurosurg. Psychiatry 92, 769\u2013775 (2021).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"67744_CR61","doi-asserted-by":"crossref","unstructured":"Couto, B., et al. Midbrain cytotoxic T cells as a distinct neuropathological feature of progressive supranuclear palsy. Brain 148, 2650\u20132657 (2025).","DOI":"10.1093\/brain\/awaf135"},{"key":"67744_CR62","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1093\/brain\/awad309","volume":"147","author":"IJ Hartnell","year":"2024","unstructured":"Hartnell, I. J. et al. Glial reactivity and T cell infiltration in frontotemporal lobar degeneration with tau pathology. Brain 147, 590\u2013606 (2024).","journal-title":"Brain"},{"key":"67744_CR63","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1002\/ana.27202","volume":"97","author":"EA Backman","year":"2025","unstructured":"Backman, E. A. et al. Nigral neuroinflammation and dopaminergic neurons in Parkinson\u2019s disease and atypical parkinsonisms. Ann. Neurol. 97, 1096\u20131109 (2025).","journal-title":"Ann. Neurol."},{"key":"67744_CR64","doi-asserted-by":"publisher","first-page":"102019","DOI":"10.1016\/j.ctrv.2020.102019","volume":"86","author":"AM Tsimberidou","year":"2020","unstructured":"Tsimberidou, A. M., Fountzilas, E., Nikanjam, M. & Kurzrock, R. Review of precision cancer medicine: evolution of the treatment paradigm. Cancer Treat. Rev. 86, 102019 (2020).","journal-title":"Cancer Treat. Rev."},{"key":"67744_CR65","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/B978-0-323-85538-9.00003-1","volume":"192","author":"NC Elson","year":"2023","unstructured":"Elson, N. C., Lewis, J. D., Shaughnessy, E. A. & Reyna, C. Lessons from other fields of medicine, Part 1: breast cancer. Handb. Clin. Neurol. 192, 101\u2013118 (2023).","journal-title":"Handb. Clin. Neurol."},{"key":"67744_CR66","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00401-019-02080-2","volume":"139","author":"E Saijo","year":"2020","unstructured":"Saijo, E. et al. 4-Repeat tau seeds and templating subtypes as brain and CSF biomarkers of frontotemporal lobar degeneration. Acta Neuropathol. 139, 63\u201377 (2020).","journal-title":"Acta Neuropathol."},{"key":"67744_CR67","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13024-024-00781-1","volume":"19","author":"Z Wang","year":"2024","unstructured":"Wang, Z. et al. Seeding activity of skin misfolded tau as a biomarker for tauopathies. Mol. Neurodegener. 19, 92 (2024).","journal-title":"Mol. Neurodegener."},{"key":"67744_CR68","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.1038\/s41588-024-01961-x","volume":"56","author":"E Miyoshi","year":"2024","unstructured":"Miyoshi, E. et al. Spatial and single-nucleus transcriptomic analysis of genetic and sporadic forms of Alzheimer\u2019s disease. Nat. Genet 56, 2704\u20132717 (2024).","journal-title":"Nat. Genet"},{"key":"67744_CR69","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1136\/jclinpath-2019-205952","volume":"72","author":"GG Kovacs","year":"2019","unstructured":"Kovacs, G. G. Molecular pathology of neurodegenerative diseases: principles and practice. J. Clin. Pathol. 72, 725\u2013735 (2019).","journal-title":"J. Clin. Pathol."},{"key":"67744_CR70","doi-asserted-by":"publisher","first-page":"4330","DOI":"10.1021\/bi2004685","volume":"50","author":"PD Dinkel","year":"2011","unstructured":"Dinkel, P. D., Siddiqua, A., Huynh, H., Shah, M. & Margittai, M. Variations in filament conformation dictate seeding barrier between three-and four-repeat tau. Biochemistry 50, 4330\u20134336 (2011).","journal-title":"Biochemistry"},{"key":"67744_CR71","doi-asserted-by":"publisher","first-page":"48165","DOI":"10.1074\/jbc.M105196200","volume":"276","author":"M Von Bergen","year":"2001","unstructured":"Von Bergen, M. et al. Mutations of tau protein in frontotemporal dementia promote aggregation of paired helical filaments by enhancing local \u03b2-structure. J. Biol. Chem. 276, 48165\u201348174 (2001).","journal-title":"J. Biol. Chem."},{"key":"67744_CR72","doi-asserted-by":"publisher","first-page":"10223","DOI":"10.1021\/bi980537d","volume":"37","author":"P Friedhoff","year":"1998","unstructured":"Friedhoff, P., Schneider, A., Mandelkow, E.-M. & Mandelkow, E. Rapid assembly of Alzheimer-like paired helical filaments from microtubule-associated protein tau monitored by fluorescence in solution. Biochemistry 37, 10223\u201310230 (1998).","journal-title":"Biochemistry"},{"key":"67744_CR73","doi-asserted-by":"publisher","first-page":"15712","DOI":"10.1073\/pnas.95.26.15712","volume":"95","author":"P Friedhoff","year":"1998","unstructured":"Friedhoff, P., Von Bergen, M., Mandelkow, E.-M., Davies, P. & Mandelkow, E. A nucleated assembly mechanism of Alzheimer paired helical filaments. Proc. Natl. Acad. Sci. 95, 15712\u201315717 (1998).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"67744_CR74","doi-asserted-by":"publisher","first-page":"686","DOI":"10.3923\/biotech.2008.686.693","volume":"7","author":"K Jessie","year":"2008","unstructured":"Jessie, K., Hashim, O. H. & Rahim, Z. Protein precipitation method for salivary proteins and rehydration buffer for two-dimensional electrophoresis. Biotechnology 7, 686\u2013693 (2008).","journal-title":"Biotechnology"},{"key":"67744_CR75","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nmeth.3901","volume":"13","author":"S Tyanova","year":"2016","unstructured":"Tyanova, S. et al. The Perseus computational platform for comprehensive analysis of (prote) omics data. Nat. Methods 13, 731\u2013740 (2016).","journal-title":"Nat. Methods"},{"key":"67744_CR76","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/nbt.2839","volume":"32","author":"JA Vizca\u00edno","year":"2014","unstructured":"Vizca\u00edno, J. A. et al. ProteomeXchange provides globally coordinated proteomics data submission and dissemination. Nat. Biotechnol. 32, 223\u2013226 (2014).","journal-title":"Nat. Biotechnol."},{"key":"67744_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou, Y. et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 10, 1523 (2019).","journal-title":"Nat. Commun."},{"key":"67744_CR78","doi-asserted-by":"publisher","first-page":"W234","DOI":"10.1093\/nar\/gkz240","volume":"47","author":"G Zhou","year":"2019","unstructured":"Zhou, G. et al. NetworkAnalyst 3.0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis. Nucleic Acids Res. 47, W234\u2013W241 (2019).","journal-title":"Nucleic Acids Res."},{"key":"67744_CR79","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1874-1","volume":"20","author":"C Hafemeister","year":"2019","unstructured":"Hafemeister, C. & Satija, R. Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression. Genome Biol. 20, 296 (2019).","journal-title":"Genome Biol."},{"key":"67744_CR80","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573\u20133587. e3529 (2021).","journal-title":"Cell"},{"key":"67744_CR81","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37437-5","volume":"14","author":"L Brase","year":"2023","unstructured":"Brase, L. et al. Single-nucleus RNA-sequencing of autosomal dominant Alzheimer disease and risk variant carriers. Nat. Commun. 14, 2314 (2023).","journal-title":"Nat. Commun."},{"key":"67744_CR82","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10802-z","volume":"10","author":"D Tsoucas","year":"2019","unstructured":"Tsoucas, D. et al. Accurate estimation of cell-type composition from gene expression data. Nat. Commun. 10, 2975 (2019).","journal-title":"Nat. Commun."},{"key":"67744_CR83","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s42003-021-02146-6","volume":"4","author":"L He","year":"2021","unstructured":"He, L. et al. NEBULA is a fast negative binomial mixed model for differential or co-expression analysis of large-scale multi-subject single-cell data. Commun. Biol. 4, 629 (2021).","journal-title":"Commun. Biol."},{"key":"67744_CR84","doi-asserted-by":"crossref","unstructured":"Korotkevich, G. et al. Fast gene set enrichment analysis. BioRxiv, https:\/\/www.biorxiv.org\/content\/10.1101\/060012v3 (2016).","DOI":"10.1101\/060012"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67744-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67744-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67744-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T15:28:58Z","timestamp":1769527738000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67744-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,31]]},"references-count":84,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["67744"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-67744-y","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,31]]},"assertion":[{"value":"22 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"I.M.V., G.G.K., and A.E.L. are inventors on a pending patent application related to diagnostic assays for movement disorders. The patent applicant is the inventors (I.M.V., G.G.K., and A.E.L.) and the University Health Network. The application is titled\n                      Diagnostic assays for movement disorders\n                      and has the application number 18\/537,455. The patent is currently pending. The application includes the SAA used in this study; however, in this manuscript, the assay is used solely as a research tool to classify brain tissue samples and not for diagnostic purposes. G.G.K. has a shared patent for 5G4 Synuclein antibody. All other authors declare no competing interests. Outside the submitted work, I.M.V. receives funding from the Michael J. Fox Foundation for Parkinson's Research and consultancy fees from Ferrer. SLF receives funding from the National Health and Medical Research Council, Australia. M.I. is a paid consultant to BioArctic AB. M.C.T receives funding from NIH, Weston Brain Foundation, Tanenbaum Institute for Research in Science of Sport, Canadian Institutes of Health Research, and in-kind funding from Roche; she has served as an advisor to Eisai, Lilly and Novo Nordisk and she conducts clinical trials for Biogen, Anavex, Janssen, Novo Nordisk, BMS, Aribio, Green Valley, UCB, Passage Bio. S.H.F. receives research Funding from the Michael J Fox Foundation for Parkinson's Research, NIH (Dystonia Coalition), Parkinson Canada, and the Weston Foundation. Honoraria from the International Parkinson and Movement Disorder Society. Consultancy\/Speaker fees from AbbVie, Lundbeck, Sunovion and Royalties from Oxford University Press. A.E.L. has served as an advisor for AbbVie, Amylyx, Aprinoia, Biogen, BioAdvance, Biohaven, BioVie, BlueRock, BMS, Denali, EG427, Ferrer, Janssen, Lilly, Northera, Pharma 2B, Sun Pharma, UCB; and Ventyx Bio; received honoraria from Sun Pharma and AbbVie; received grants from Brain Canada, Canadian Institutes of Health Research, Edmond J Safra Philanthropic Foundation, Krembil Brain Institute, Michael J. Fox Foundation, Parkinson Foundation, Parkinson Canada, Weston Foundation; is serving as an expert witness in litigation related to paraquat and Parkinson\u2019s disease, received publishing royalties from Elsevier, Saunders, Wiley-Blackwell, Johns Hopkins Press, and Cambridge University Press. G.G.K. reports personal fees from Parexel, other funding from Rossy Family Foundation, from Edmond Safra Foundation, grants from Krembil Foundation, MSA Coalition, Michael J. Fox Foundation, Parkinson Canada, NIH, Canada Foundation for Innovation, and Ontario Research Fund; in addition, G.G.K. received royalties from Wiley, Cambridge, and Elsevier publishers. None of these had an influence on this study. S.L.; E.S.; J.F-I.; S.L.; J.L.; H.T.; B.C.; N.G.R; S.H.Q.; A.M.K.; A.K.; K.S.; E.R.; N.P.V. and T.A. declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1006"}}